Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications.

Literature DB >> 20614842

In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications.

Andrew D Krystal¹.

Abstract

Mesh：

Substances：

Year: 2010 PMID： 20614842 PMCID： PMC2894424 DOI： 10.1093/sleep/33.7.859

Source DB: PubMed Journal: Sleep ISSN： 0161-8105 Impact factor: 5.849

× No keyword cloud information.

15 in total

1. Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype.

Authors: I Tobler; C Kopp; T Deboer; U Rudolph
Journal: Proc Natl Acad Sci U S A Date: 2001-05-15 Impact factor: 11.205

2. Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.

Authors: G Puia; S Vicini; P H Seeburg; E Costa
Journal: Mol Pharmacol Date: 1991-06 Impact factor: 4.436

3. Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation.

Authors: Viviane S Hambrecht-Wiedbusch; Elizabeth A Gauthier; Helen A Baghdoyan; Ralph Lydic
Journal: Sleep Date: 2010-07 Impact factor: 5.849

4. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.

Authors: Miroslav M Savić; Dragan I Obradović; Nenad D Ugresić; James M Cook; Wenyuan Yin; Dubravko R Bokonjić
Journal: Pharmacol Biochem Behav Date: 2004-10 Impact factor: 3.533

5. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

Authors: R M McKernan; T W Rosahl; D S Reynolds; C Sur; K A Wafford; J R Atack; S Farrar; J Myers; G Cook; P Ferris; L Garrett; L Bristow; G Marshall; A Macaulay; N Brown; O Howell; K W Moore; R W Carling; L J Street; J L Castro; C I Ragan; G R Dawson; P J Whiting
Journal: Nat Neurosci Date: 2000-06 Impact factor: 24.884

6. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.

Authors: Rosa L Fradley; Martin R Guscott; Sharlene Bull; David J Hallett; Simon C Goodacre; Keith A Wafford; Elizabeth M Garrett; Richard J Newman; Gillian F O'Meara; Paul J Whiting; Thomas W Rosahl; Gerard R Dawson; David S Reynolds; John R Atack
Journal: J Psychopharmacol Date: 2006-11-08 Impact factor: 4.153

7. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.

Authors: Mark Pollack; Gustavo Kinrys; Andrew Krystal; W Vaughn McCall; Thomas Roth; Kendyl Schaefer; Robert Rubens; James Roach; Holly Huang; Ranga Krishnan
Journal: Arch Gen Psychiatry Date: 2008-05

8. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.

Authors: Maurizio Fava; Gregory M Asnis; Ram Shrivastava; Bruce Lydiard; Bijan Bastani; David Sheehan; Thomas Roth
Journal: J Clin Psychopharmacol Date: 2009-06 Impact factor: 3.153

9. The modulation of synaptic GABA(A) receptors in the thalamus by eszopiclone and zolpidem.

Authors: Fan Jia; Peter A Goldstein; Neil L Harrison
Journal: J Pharmacol Exp Ther Date: 2008-11-25 Impact factor: 4.030

Review 10. A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice.

Authors: Andrew D Krystal
Journal: Sleep Med Rev Date: 2009-01-18 Impact factor: 11.609

3 in total